BBAGF OTC
BB Biotech AG
1W: +0.0%
1M: +31.8%
3M: +0.0%
YTD: +0.0%
1Y: +3.9%
3Y: +14.9%
$64.36
+3.18 (+5.20%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$4.9B
52W Range33.6454-76.0579
Volume5
Avg Volume22
Beta0.58
Dividend$2.78
Analyst Ratings
No analyst coverage
Company Info
CEODaniel Koller
Employees10
SectorFinancial Services
IndustryAsset Management
IPO Date2015-10-12
Websitebbbiotech.ch/ch-en/private
Seestrasse 16
Kusnacht CH-8700
CH
Kusnacht CH-8700
CH
41 44 267 67 00
About BB Biotech AG
BB Biotech AG provides investment services for biotechnology sector. It invests in portfolio of companies that are engaged in developing and marketing of innovative biotech drugs. It offers investors a exposure to a focused portfolio of predominantly-US small-to-mid-cap biotech companies developing therapeutic products, towards cell, gene and particularly RNA-based technologies. The company was founded on November 9, 1993 and is headquartered in Schaffhausen, Switzerland.
Latest News
No recent news
Recent Insider Trades
No insider trades found